Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Virology

• Publication date

  1995-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.69.6.3712-3720.1995PMID 7745720PMCID PMC189087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Replication of primary HIV-1 isolates is inhibited in PM1 cells expressing sCD4-KDEL.

  1996cited by this paper
• Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages.

  1995cited by this paper
• Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope

  1994cited by this paper
• Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization

  1994cited by this paper
• Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.

  1993cited by this paper
• Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

  1993cited by this paper
• Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism

  1992cited by this paper
• Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

  1992cited by this paper
• Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

  1992cited by this paper
• Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.

  1992cited by this paper
• Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.

  1992influential reference
• Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.

  1991cited by this paper
• Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture

  1991cited by this paper
• Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene

  1991cited by this paper
• Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

  1991influential reference
• Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4

  1991cited by this paper
• High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

  1990cited by this paper
• HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

  1990cited by this paper
• Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.

  1990cited by this paper
• Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome

  1990cited by this paper
• The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue

  1990cited by this paper
• Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2.

  1990cited by this paper
• Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

  1990cited by this paper
• Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion

  1990cited by this paper
• Specific tropism of HIV-1 for microglial cells in primary human brain cultures.

  1990cited by this paper
• HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

  1989cited by this paper
• Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines.

  1989cited by this paper
• Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

  1989cited by this paper
• Biologic features of HIV-1 that correlate with virulence in the host.

  1988cited by this paper
• Biologically diverse molecular variants within a single HIV-1 isolate

  1988cited by this paper
• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

  1988cited by this paper
• Extensive variation of human immunodeficiency virus type-1 in vivo

  1988cited by this paper
• Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates

  1988influential reference
• Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

  1988cited by this paper
• Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex

  1988cited by this paper
• Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

  1988cited by this paper
• Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

  1988cited by this paper
• Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.

  1988cited by this paper
• Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

  1987cited by this paper
• Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.

  1986influential reference
• Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS

  1986cited by this paper
• Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

  1986cited by this paper
• HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

  1986cited by this paper
• The role of mononuclear phagocytes in HTLV-III/LAV infection.

  1986cited by this paper
• Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.

  1986cited by this paper
• Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.

  1985cited by this paper
• Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

  1985cited by this paper
• A molecular clone of HTLV-III with biological activity

  1985cited by this paper
• Edinburgh Research Explorer Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1

  year unknowncited by this paper

• Assembly of CCR5 with gp120 inhibits the HIV infectivity specifically in T cells

  2025cites this paper
• RNase P-Associated External Guide Sequences Inhibit HIV-1 Infection by Shutting Down Human CCR5 Expression

  2025cites this paper
• Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmission

  2025cites this paper
• HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors’ Phenotypic Susceptibility

  2024cites this paper
• CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture

  2024cites this paper
• Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G

  2023cites this paper
• RNase P Ribozyme Effectively Inhibits Human CC-Chemokine Receptor 5 Expression and Human Immunodeficiency Virus 1 Infection

  2023influential citation
• Rational Engineering of a Sub-Picomolar HIV-1 Blocker

  2022cites this paper
• RAISING is a high-performance method for identifying random transgene integration sites

  2022influential citation
• Pre-clinical evaluation of antiproteases as potential candidates for HIV-1 pre-exposure prophylaxis

  2022cites this paper
• The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate

  2021cites this paper
• Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application

  2021cites this paper
• Altered HIV-1 mRNA Splicing Due to Drug-Resistance-Associated Mutations in Exon 2/2b

  2021cites this paper
• Disruption of HIV-1 Co-Receptors CCR5 and CXCR4 in Primary Human T Cells and Hematopoietic Stem and Progenitor Cells Using Base Editing.

  2021cites this paper
• Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV‐1 Infection

  2020cites this paper
• Identification of Circulating Biomarkers of HIV Disease Progression by

  2020cites this paper
• A new cell line for assessing HIV-1 antibody dependent cellular cytotoxicity against a broad range of variants.

  2020cites this paper
• Methods and products for reawakening retrocyclins Methods and products for reawakening retrocyclins

  2020cites this paper
• A High-Throughput HIV-1 Drug Screening Platform, Based on Lentiviral Vectors and Compatible with Biosafety Level-1

  2020cites this paper
• In vitro anti-HIV activity of some Indian medicinal plant extracts

  2020cites this paper
• Clinically relevant CCR5 editing in primary CD4+ T cells with TALEN confers resistance to HIV-1 infection

  2020influential citation
• Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance

  2019cites this paper
• Avirulins, a Novel Class of HIV-1 Reverse Transcriptase Inhibitors Effective in the Female Reproductive Tract Mucosa

  2019cites this paper
• Recoding of viral mRNAs by –1 programmed ribosome frameshifting

  2019influential citation
• Quantification of HIV-2 DNA in Whole Blood.

  2019influential citation
• The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models

  2019cites this paper
• Efficient HIV-1 Trans Infection of CD4+ T Cells Occurs in the Presence of Antiretroviral Therapy

  2019cites this paper
• Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G

  2019cites this paper
• The evolution of HIV‐1 entry phenotypes as a guide to changing target cells

  2018cites this paper
• HIV infection results in clonal expansions containing integrations within pathogenesis-related biological pathways.

  2018cites this paper
• The Noncoding RNA nc886 Regulates PKR Signaling and Cytokine Production in Human Cells

  2018cites this paper
• The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors

  2018cites this paper
• Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers

  2018cites this paper
• In Vivo Murine-Matured Human CD3+ Cells as a Preclinical Model for T Cell-Based Immunotherapies

  2017influential citation
• Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor

  2017cites this paper
• Continued Utilization of CCR 5 Coreceptor by a Newly Derived T-Cell Line-Adapted Isolate of Human Immunodeficiency Virus Type 1

  2017cites this paper
• Modulation of HIV-1-host cell pathways : from virus entry to latency

  2017cites this paper
• Detection and characterization of Human Herpes Virus -8 in an HIV-infected cohort in Cameroon

  2017cites this paper
• HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity

  2017cites this paper
• Rice endosperm is cost‐effective for the production of recombinant griffithsin with potent activity against HIV

  2016cites this paper
• Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates

  2016cites this paper
• CIB1 and CIB2 are HIV-1 helper factors involved in viral entry

  2016cites this paper
• The potential of broadly neutralizing HIV antibodies to function as microbicides

  2016cites this paper
• Chlamydia trachomatis Infection of Endocervical Epithelial Cells Enhances Early HIV Transmission Events

  2016cites this paper
• Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains

  2015cites this paper
• Chemokines and HIV: The First Close Encounter

  2015cites this paper
• The dual CCR5 and CCR2 inhibitor cenicriviroc does not redistribute HIV into extracellular space: implications for plasma viral load and intracellular DNA decline.

  2015cites this paper
• Combination of the R263K and M184I/V Resistance Substitutions against Dolutegravir and Lamivudine Decreases HIV Replicative Capacity

  2015cites this paper
• The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy

  2015cites this paper
• mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5

  2015influential citation
• Toll-Like Receptor 3 Signalling UpRegulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD 4 ( + ) T Cells

  2014cites this paper
• Culture Virus Type 1 in Cell Measure Replication Efficiency of Human Assay That Uses Flow Cytometry To Recombinant Virus, Growth Competition Evaluation of a Multiple-Cycle,

  2014cites this paper
• The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.

  2014cites this paper
• Exposure to Entry Inhibitors Alters HIV Infectiousness and Sensitivity to Broadly Neutralizing Monoclonal Antibodies

  2014cites this paper
• Characterization of 90K/LGALS3BP as antiviral factor

  2014cites this paper
• Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4+ T Cells

  2014cites this paper
• Candidate microbicides and their mechanisms of action.

  2014cites this paper
• A neutralization assay for chikungunya virus infections in a multiplex format

  2014cites this paper
• Cobinding to CCR5 Wide Target Compatibility and Synergic R4.0 with Different HIV-1 Blockers Reveals Combination of the CCL5-Derived Peptide

  2014cites this paper
• Dynamin-Dependent Endocytosis Cell-to-Cell Transmission via Productive Entry of HIV-1 during

  2014cites this paper
• Impact of maraviroc-resistant and low-CCR5-adapted mutations induced by in vitro passage on sensitivity to anti-envelope neutralizing antibodies.

  2014cites this paper
• Combination of the CCL5-Derived Peptide R4.0 with Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5

  2014cites this paper
• The search for a T cell line for testing novel antiviral strategies against HIV-1 isolates of diverse receptor tropism and subtype origin.

  2014cites this paper
• development Stimulated plasmacytoid dendritic cells impair human T-cell

  2013cites this paper
• Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4 pos

  2013cites this paper
• Conformational Epitope Consisting of the V3 and V4 Loops as a Target for Potent and Broad Neutralization of Simian Immunodeficiency Viruses

  2013cites this paper
• Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis

  2013influential citation
• Non-coding RNA in T cell activation and function

  2013cites this paper
• Host-specific innate and adaptive immune responses in therapy-naive human immunodeficiency virus 1 infected patients

  2013cites this paper
• Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages

  2013cites this paper
• Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors.

  2013cites this paper
• In vitro and in vivo testing of conditionally replicating SIV and HIV-1 strains to study viral gene expression

  2013cites this paper
• Differential Expression of Candidate Virus Receptors in Human T Lymphocytes Prone or Resistant to Infection with Patient-Derived Hepatitis C Virus

  2013cites this paper
• Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail

  2013cites this paper
• Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) In vitro and in vivo testing of conditionally replicating SIV and HIV-1 strains to study viral gene expression

  2013cites this paper
• An AUG codon upstream of rev and env open reading frames ensures optimal translation of the simian immunodeficiency virus Env protein.

  2013cites this paper
• Macaques Immunized with Live Attenuated SIV (SIV) Replication by CD8+ T Lymphocytes from Inhibition of Simian Immunodeficiency Virus

  2013cites this paper
• Surfactant Protein D Modulates HIV Infection of Both T-Cells and Dendritic Cells

  2013cites this paper
• ImmunogenicityInhibitor with Greatly Reduced A Rationally Engineered Anti-HIV Peptide

  2013cites this paper
• RNase P-Associated External Guide Sequence Effectively Reduces the Expression of Human CC-Chemokine Receptor 5 and Inhibits the Infection of Human Immunodeficiency Virus 1

  2012cites this paper
• Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model.

  2012cites this paper
• TranslationRegulate Rev and Env Protein Immunodeficiency Virus SIVmac239 Upstream AUG Codons in the Simian

  2012cites this paper
• Upstream AUG Codons in the Simian Immunodeficiency Virus SIVmac239 Genome Regulate Rev and Env Protein Translation

  2012influential citation
• Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor

  2012cites this paper
• Saquinavir Inhibits Early Events Associated with Establishment of HIV-1 Infection: Potential Role for Protease Inhibitors in Prevention

  2012cites this paper
• Hepatitis C Virus Infection of Human T Lymphocytes Is Mediated by CD5

  2012cites this paper
• Lymphocytes Is Mediated by CD5 Hepatitis C Virus Infection of Human T

  2012cites this paper
• Tat has a dual role in simian immunodeficiency virus transcription.

  2012cites this paper
• Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication.

  2012cites this paper
• The role of the alternative coreceptor GPR15 in SIV tropism for human cells.

  2012cites this paper
• Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection

  2012cites this paper
• Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load

  2012cites this paper
• Inhibition of HIV-1 Infection by Human α-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae

  2012cites this paper
• Intercellular Adhesion Molecule 1 Promotes HIV-1 Attachment but Not Fusion to Target Cells

  2012cites this paper
• Specific Redistribution Effect that Results in Increased

  2012cites this paper
• A Rationally Engineered Anti-HIV Peptide Fusion Inhibitor with Greatly Reduced Immunogenicity

  2012cites this paper
• Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.

  2012cites this paper
• Brief Engagement of NKp30 on V (cid:1) 1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication

  2012cites this paper
• Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate Microbicide

  2012cites this paper